A Prospective, Multicentric, Observational Study to Investigate the Effectiveness of an Education Support Program on Medication Adherence in Italian Real Life RA Patients Treated With Abatacept SC
Phase of Trial: Phase IV
Latest Information Update: 19 Jul 2018
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms TIGHT
- Sponsors Bristol-Myers Squibb
- 31 Aug 2018 Biomarkers information updated
- 11 Jul 2018 Planned End Date changed from 30 Jun 2021 to 4 Aug 2021.
- 11 Jul 2018 Planned primary completion date changed from 30 Jun 2021 to 4 Aug 2019.